Table 7. Impact of PRIME mental healthcare plan on individual-level outcomes.
| Midline | Endline | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean (SD) or N (%) | Mean change from BL (β) or RR | 95% CI | Cohen’s d | N | Mean (SD) or N (%) | Mean change from BL (β) or RR | 95% CI | Cohen’s d | |
| Depression | ||||||||||
| PHQ-9 score | 110 | 4.7 (4.32) | −7.32*** | −9.64 to −5.00 | −0.59 | 111 | 4.8 (4.60) | −7.22*** | −9.54 to −4.89 | −0.58 |
| WHODAS | 110 | 18.9 (18.83) | −16.77*** | −23.83 to −9.70 | −0.44 | 111 | 19.8 (20.92) | −15.89*** | −23.03 to −8.74 | −0.41 |
| AUD | ||||||||||
| AUDIT score | 135 | 10.4 (9.87) | −15.00*** | −19.26 to −10.75 | −0.59 | 142 | 15.7 (10.74) | −9.68*** | −14.35 to −5.00 | −0.34 |
| SIP-2R score | 135 | 8.5 (9.30) | −11.50*** | −14.93 to −8.08 | −0.57 | 142 | 10.9 (9.52) | −9.13*** | −12.73 to −5.54 | −0.42 |
| WHODAS score | 135 | 12.3 (15.77) | −9.84*** | −13.83 to −5.85 | −0.42 | 142 | 13.6 (14.33) | −8.57*** | −12.64 to −4.49 | −0.35 |
| Psychosis | ||||||||||
| PANSS score | 87 | 6.7 (6.84) | −6.30 *** | −9.44 to −3.15 | −0.42 | 86 | 6.6 (7.72) | −6.42*** | −9.55 to −3.28 | −0.43 |
| WHODAS score | 87 | 21.0 (18.45) | −9.19* | −16.90 to −1.47 | −0.25 | 86 | 16.7 (18.67) | −13.56*** | −20.78 to −6.34 | −0.40 |
| Epilepsy | ||||||||||
| Number of seizures | 40 | 3.9 (10.02) | 0.35 | 0.29 to 0.42 | 38 | 2.7 (5.60) | 0.24 | 0.29 to 0.42 | ||
| WHODAS score | 40 | 16.0 (18.47) | −3.14 | −10.99 to 4.71 | −0.12 | 38 | 14.5 (15.95) | −4.71 | −12.32 to 2.91 | −0.20 |
*p < 0.05;
***p < 0.001.
AUDIT, Alcohol Use Disorders Identification Test; BL, baseline; PANSS, Positive and Negative Syndrome Scale; PHQ-9, Patient Health Questionnaire–9 item; PRIME, Programme for Improving Mental Health Care; RR, risk ratio; SD, standard deviation; SIP-2R, Short Inventory of Problems–Revised; WHODAS, WHO Disability Assessment Schedule.